Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
124 participants
INTERVENTIONAL
2020-12-01
2024-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Point-of-care EEG in the Pediatric Emergency Department
NCT05418634
Seizure Rescue Medication: Caregiver Education in a Simulation Setting
NCT03562351
Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction
NCT04333082
Epileptic Seizures in Intensive Care Units
NCT03860467
EEG in In-hospital Patients With Seizure or Altered Mental State
NCT02383745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This randomized controlled intervention study performed at the simulation center of the medical intensive care units (ICUs) at the University Hospital Basel is to investigate the effectiveness of pre-briefing physicians with both the current guideline on Status epilepticus (SE) treatment or a consolidated "one page" guideline regarding quality enhancement of the physicians' clinical performances..
Physicians from different medical specialties and with different duration of clinical experience will be enrolled. Participants will be randomly assigned to one of the following three pre-briefing groups: (1) no pre-briefing prior to the simulation training; (2) pre-briefing with the current SE treatment guidelines; (3) pre-briefing with the consolidated "one page" SE treatment guideline.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No pre-briefing prior to the simulation training
No pre-briefing prior to the simulation training
No Pre-briefing
no instruction of the study participants prior to the simulation training
Pre-briefing with the current SE treatment guidelines
pre-briefing with the current SE treatment Guidelines published by the American Epilepsy Society
Pre-briefing with the current SE treatment guidelines
instruction of the study participants according to the evidence-based guideline for the treatment of SE published by the American Epilepsy Society prior to the simulation training
pre- briefing with consolidated SE treatment guideline
pre-briefing with the consolidated "one page" SE treatment guideline
Pre-briefing with a consolidated "one page" SE treatment guide
instruction of the study participants with a consolidated "one page" SE treatment guide prior to the simulation training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pre-briefing with the current SE treatment guidelines
instruction of the study participants according to the evidence-based guideline for the treatment of SE published by the American Epilepsy Society prior to the simulation training
Pre-briefing with a consolidated "one page" SE treatment guide
instruction of the study participants with a consolidated "one page" SE treatment guide prior to the simulation training
No Pre-briefing
no instruction of the study participants prior to the simulation training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raoul Sutter, PD Dr. MD
Role: PRINCIPAL_INVESTIGATOR
Clinic for Intensive Care Medicine, University Hospital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinic for Intensive Care Medicine, University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Requ_2019-00168; me19Sutter3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.